white_logo.svg
magnifying-glass.svg
Houston Methodist Academic Institute
NEWSLETTER
August 2021
magnifying-glass.svg
close-24px__1_.svg
result
close-24px__1_.svg
result
Houston Methodist Hospital Moves Up the U.S. News & World Report Honor Roll
img_1_US_News_21_HoustonMetho_Badge-HOS-Honor-.jpg
U.S. News & World Report has ranked Houston Methodist Hospital No. 16 on its national Honor Roll, moving it up the list of the top hospitals in the country. This also is the 10th year in a row it has been named the No. 1 hospital in Texas. The rankings are based on scores in patient care, patient safety, outcomes, nursing, advanced technology and reputation. U.S. News has ranked Houston Methodist Hospital in at least one specialty for the past 29 years and has placed it on its Honor Roll for the fifth time. This year, Houston Methodist Hospital is ranked in 10 specialties, the most of any hospital in the state. Six of the ranked specialties appear in the top 20, and all are ranked in the top 30 in the country. These high rankings moved Houston Methodist Hospital from No. 20 on the Honor Roll to No. 16 this year. Among our community hospitals, Houston Methodist Sugar Land had a nationally ranked specialty for the first time in diabetes and endocrinology at No. 49. It ranked No. 6 in Houston and No. 8 in Texas. Houston Methodist Willowbrook was ranked No. 7 in Houston and No. 12 in Texas. HMH received the maximum points for superior performance in 17 out of 17 common adult procedures and conditions including abdominal aortic aneurysm repair; aortic valve surgery; heart bypass surgery; heart failure; colon cancer surgery; chronic obstructive pulmonary disease (COPD); hip replacement; knee replacement; lung cancer surgery; aortic valve replacement (TAVR); kidney failure; stroke; pneumonia; hip fracture; diabetes; heart attack; and back surgery (spinal fusion). Ranked specialties include: cancer at No. 23; cardiology/heart surgery at No. 15; diabetes and endocrinology at No. 16; gastroenterology/GI surgery at No. 10; geriatrics at No. 22; gynecology at No. 19; neurology/neurosurgery at No. 21; orthopedics at No. 12; pulmonology and lung surgery at No. 19; and urology at No. 29. The rankings are online at http://health.usnews.com/best-hospitals.
This is a tremendous achievement for our physicians and employees who dedicate themselves every day to our patients – especially now as we celebrate this news during another surge in the pandemic. These national accolades are something to be proud of, but most important, our patients are benefiting from all of our hard work. Ultimately, they are the reason we need to be one of the best hospital systems in the country.
bottom-quotation-sign.svg
Marc Boom, M.D.,
President and CEO of Houston Methodist
Digital Methodology
Acetyl-CoA Synthetase 2 connects obesity and myeloma pathogenesis Comprehensive detailed analyses using murine models and cell lines identify acetyl CoA synthetase 2 as a pivotal player controlling the dynamic communication between adipocytes and myeloma cells during myeloma pathogenesis. Read more in Digital Methodology.
Announcements
The George and Angelina Kostas Research Center for Cardiovascular Nanomedicine International Meeting
The George and Angelina Kostas Research Center for Cardiovascular Nanomedicine will host its annual international meeting Monday, Oct. 18, 2021. This virtual conference will be from 9 a.m. to 5:30 p.m. The course is directed by John P. Cooke, MD, PhD, and Alessandro Grattoni, PhD. This conference will foster collaborations between clinicians and research scientists from around the world who are working toward high-impact solutions that apply nanomedicine approaches to diagnose and treat cardiovascular diseases. International experts will showcase the use of emerging, novel technologies in nanomedicine and their applications for healing patients with heart disease. Presentations focus on the latest medical advances, treatments, leading-edge research, and future trends in cardiovascular disease and nanomedicine. The featured speakers are:
  • Bruna Corradetti, PhD, MSc, Houston Methodist
  • Pieter Cullis, PhD, University of British Columbia/Nanomedicines Innovation Network
  • Tejal Desai, PhD, University of California San Francisco
  • Eduardo Marbán, MD, PhD, Cedars-Sinai Medical Center
  • Joan Nichols, PhD, Houston Methodist
  • Haifa Shen, MD, PhD, Houston Methodist
  • Francesca Taraballi, PhD, Houston Methodist
  • Omid Veiseh, PhD, Rice University
To register, visit www.Kostas.Health.
img_3_Kostas-Meeting-Cvent_518x324.jpg
Hu Lab website launches
The website for the Chih-Chi Andrew Hu, PhD, laboratory is now published. The Hu Lab investigates the biology of the endoplasmic reticulum (ER) in normal and malignant B cells. The work from the laboratory establishes that inhibiting the IRE-1/XBP-1s pathway of the ER stress response and activating IRE-1’s interacting protein, STING, are effective therapeutic strategies for B cell cancer and graft-versus-host disease. It also develops novel small molecules to target these pathways. Investigators continue to identify and characterize ER-resident proteins that can be targeted for therapy of human diseases. You can access the website at https://hu.hmailabs.org/.
Tang website launches
The website for the Chih-Hang Anthony Tang, PhD, laboratory is now published. The mission of the Tang Lab is to contribute to the treatment of cancer through the understanding of mechanisms of how tumors interact with immune systems in tumor microenvironment. You can access the website at https://tang.hmailabs.org/.
Fall 2021 Virtual Research Methods Bootcamp
Curious about research but not sure how to get started? Join your interprofessional colleagues across our system as we turn your research idea into an actionable research plan. Log on virtually for an hour on Tuesdays at noon through Sept. 21 and you’ll leave ready to put your research into action. Participants will leave this eight-week workshop series with a completed research protocol ready to be submitted to the IRB. To register, email us at: academicrequests@houstonmethodist.org.
Translational Quality seminar series
The Translational Quality seminar series will cover quality systems and regulations that govern the production of clinical grade products for research. The Aug. 12 topic will be from noon to 1 p.m. The topic is “Investigations.” Click here for the link to this virtual seminar.
Annual Houston Methodist Cancer Symposium
The Ninth Annual Houston Methodist Cancer Symposium will be from 8 a.m. to 4:30 p.m. Friday, Aug. 27. The virtual conference is dedicated to the science and clinical care of solid and hematologic malignancies. The meeting will bring together Houston Methodist scientists and physicians from a broad spectrum of fields, including basic, clinical and epidemiological research. A wide range of topics will be covered from innovative translational science to clinical updates with strategies for implementation in current clinical practice. The program will provide education focused on improving patient care, research collaboration and leading medicine. Register by clicking here.
Introduction to Mindfulness
This two-hour online course is offered monthly and explores the basic practice of mindfulness, how it can improve health and well-being in everyday life and in the workplace. In this course, learners will be introduced to three formal mindfulness practices and three informal practices. Continuing education credits are available for physicians and nurses. Next course is Sept 29, 7 a.m. to 9 a.m. To register, follow the hyperlink on the flyer for your selected class.
Praying for each other
It has been a little over a year since the launch of the Prayer Connect Team at Houston Methodist Hospital. Every week, an email has been sent out to this community with requests to pray over. In that time, nearly 160 Methodist employees have committed to pray for more than 500 requests from our colleagues and community. We believe that staying connected is vital to our wellbeing, so please consider joining the chaplains in this initiative. If you would like to join us in praying for the requests of our employees and community, please reply to this email or contact Michela deTranaltes, Project Specialist for Grace Ministries at mdetranaltes@houstonmethodist.org, so we can add you to our confidential online community. If you would like to submit a prayer, either text PRAYER to 45991 or email us at HMHPrayerRequest@houstonmethodist.org.
Hang Ten: Employee Support Group
Hang Ten provides a safe and confidential environment for mutual support. A chaplain will facilitate the group and introduce life tools such as mindfulness, intentionality and reframing.
Each session will stand alone, so feel free to log on any week for as long as your time permits. We meet every Tuesday from 12-1 pm. The recurring meeting link is below:
Join WebEx meeting
Meeting number (access code): 130 671 0123 Meeting password: jFV7JBsmK72 Tap to join from a mobile device (attendees only) 404-397-1503,,1306710123## US Toll 877-209-1359,,1306710123## US TF
Join by phone
404-397-1503 US Toll 877-209-1359 US TF
Accolades
Congratulations to Ericka Greene, MD, on her induction into the 2021 Texas A&M College of Medicine Distinguished Medical Educators in recognition of her demonstrated excellence in medical education both as educator and leader in education in the areas of direct teaching, curriculum development, mentorship, leadership, and/or educational research. Greene has been instrumental in leading the Practice of Medicine courses for the Houston-based EnMed medical school program from its inception in 2019. She also serves as the program director for the Houston Methodist Neurology residency program and selected for the inaugural Houston Methodist Academic Institute Clinician Educator cohort.
Texas A&M College of Medicine Department of Medical Education recently named the 2021 Recipients of the inaugural annual MDED Career Educator Awards to recognize and honor members within the department of Medical Education for their dedication and outstanding teaching/leadership as an Early career or a Mid-Late career educator from each of the regional campuses. Congratulations to Stacy Norton, MD, obstetrics and gynecology faculty at the Houston Methodist Willowbrook site, recipient of the early career educator award, Andrew Lee, MD, chair of the department of ophthalmology at Houston Methodist Hospital, and David Lim, MD, surgery clerkship director at the Willowbrook site, who both received the mid-late career educator award. All are so deserving of this esteemed honor as inaugural recipients of these awards!
Congratulations to Ruby Shah, MD, MPD, on receiving the 2020 Innovations in Education Award from the Texas A&M College of Medicine Academy of Distinguished Medical Educators (ADME). The awarded project establishes an Interprofessional Telehealth Clinic for High Risk patients in the Internal Medicine Department. Dr. Shah and her team successfully completed the pilot phase targeting patients lost to follow up during COVID, involving MS1-MS3 students with a team of IM faculty and Pharm D faculty completing approximately 200 telephone calls to get patients back in to the clinic who had not been seen in over a year and over 6 months for those over 65. The project will continue to target telehealth follow up with diabetic patients out of this same population and create an IPE elective or selective campus wide that students can participate in. Great work, Dr. Shah and team!
EnMed holds inaugural White Coat Ceremony for its largest class
Engineering Medicine (EnMed) recently had its first White Coat Ceremony for the class of 2025. At the ceremony, EnMed students received their first white coats, the most common symbol of the medical profession for more than a century. The annual event encourages new medical students to begin their education by upholding the highest values and standards of their profession. Roderic Pettigrew, MD, PhD, was joined by leaders from the Texas A&M College of Medicine, the Texas A&M College of Engineering and Houston Methodist in welcoming the new class. The event featured a keynote address by Alan Lumsden, MD, Walter W. Fondren III Presidential Distinguished Chair at the DeBakey Heart & Vascular Center, and chair of the Department of Cardiovascular Surgery at Houston Methodist. EnMed’s class of 2025 consists of 49 students. Of the class, 40% are female, 32% are from out of state, and the average GPA is 3.75.
Image from Houston Business Journal
The Center for RNA Therapeutics at Houston Methodist Hospital has been named a finalist for the Houston Business Journal’s 2021 Innovation Award. The honorees will be featured in a special section of the Houston Business Journal's Sept. 24 weekly edition and celebrated in via an online event and in-person at an event at 11 a.m. on Sept. 23 at the Marriott Marquis downtown.
NIH News
Webinar Available on IACUC Responsibilities Regarding Service Animals Are you involved in animal programs or working with the Institutional Animal Care and Use Committee (IACUC)? Check out this webinar, where Drs. Axel Wolff and Ron Banks discuss laws and regulations relevant to providing access to research facilities for service animals. Further Demographic Analyses of NIH R01 Grant Outcomes of T32 Postdoctoral Participants Postdoctoral NIH T32 programs aim to provide select trainees with experience to enable successful career and research development. In a previous posting, we presented NIH career development, or K award, and R01 equivalent research grant outcomes of participants in post-doctoral T32 programs. Here we present further analyses focusing on the association of under-represented minority (URM) status with subsequent K or R01 awards.
COVID-19 Resources
Houston Methodist provides a variety of tools to facilitate collaborative research projects related to coronavirus. The following resources are available at https://www.tmc.edu/coronavirus-updates/

  • Elsevier Coronavirus Research Hub Curated COVID-19 Funding Opportunities
  • National Institutes of Health Coronavirus (COVID-19) Resources
  • PURE Coronavirus Portal for Research Collaboration
  • Read about our COVID-19 research on the Methodology COVID-19 News page.
    Read our seven-step process as told to the Harvard Business Review that can help employers decide about employee-mandated COVID-19 vaccinations .
    In the Media
    Daniel Bushyhead, MD, provided medical expert comments on Crohn’s disease, a chronic inflammatory bowel disease. The resulting U.S. News & World Report article was picked up by MSN and Yahoo.
    Gavin Britz, MD, recently spoke with Lifewire about using virtual reality technology in neurosurgery.
    Alysia Robichau, MD, a sports medicine physician at Houston Methodist The Woodlands, spoke with the Houston Chronicle’s David Barron for a story on the intense pressure of professional gymnastics, and the phenomenon known as the “twisties” recently experienced by Simon Biles at the 2020 Olympic Games in Tokyo. As both a sports medicine physician and a former elite gymnast, Dr. Robichau has a unique perspective on this topic. You can read the story online here.
    Job Postings
    We have job openings in the Academic Institute. Please visit the links below to find one that interests you.
    • Senior Science Editor
    Screen_Shot_2021-08-04_at_10.15.06_AM.png
    Policy Reminders from the Business Practices Office
    BP in Practice is an educational reminder designed to raise awareness regarding Business Practices hot topics, relevant laws and policies & procedures. Find archives of BP in Practice here.
    • The August 2021 issue of BP in Practice focuses on the topic of being transparent in the workplace regarding conflicts of interest or even perceived conflicts of interest. The June edition provides information on how to recognize these weak spots.
    • Use these links to access PDFs of System Policies BP01 and BP07. If you have questions, contact the BP EthicsLine at 800.500.0333 or visit tmhs.myethicsline.com.
    Publications
    The publications with the highest impact factors posted in Scholars, July 1 – July 30, 2021, include:
    Dexmedetomidine or propofol for sedation in mechanically ventilated adults with sepsis
    Hughes, C. G., Mailloux, P. T., Devlin, J. W., Swan, J. T., Sanders, R. D., Anzueto, A., Jackson, J. C., Hoskins, A. S., Pun, B. T., Orun, O. M., Raman, R., Stollings, J. L., Kiehl, A. L., Duprey, M. S., Bui, L. N., O’Neal, H. R., Snyder, A., Gropper, M. A., Guntupalli, K. K., ... Pandharipande, P. P. (2021). Dexmedetomidine or propofol for sedation in mechanically ventilated adults with sepsis. New England Journal of Medicine, 384(15), 1424-1436. https://doi.org/10.1056/NEJMoa2024922
    Valve Academic Research Consortium 3
    Généreux, P., Piazza, N., Alu, M. C., Nazif, T., Hahn, R. T., Pibarot, P., Bax, J. J., Leipsic, J. A., Blanke, P., Blackstone, E. H., Finn, M. T., Kapadia, S., Linke, A., Mack, M. J., Makkar, R., Mehran, R., Popma, J. J., Reardon, M., Rodes-Cabau, J., ... Leon, M. B. (2021). Valve Academic Research Consortium 3: Updated endpoint definitions for aortic valve clinical research. European heart journal, 42(19), 1825-1857. https://doi.org/10.1093/eurheartj/ehaa799
    A cohort study and meta-analysis of isolated diastolic hypertension
    Jacobsen, A. P., Al Rifai, M., Arps, K., Whelton, S. P., Budoff, M. J., Nasir, K., Blaha, M. J., Psaty, B. M., Blumenthal, R. S., Post, W. S., & Mcevoy, J. W. (2021). A cohort study and meta-analysis of isolated diastolic hypertension: Searching for a threshold to guide treatment. European heart journal, 42(21), 2119-2129. https://doi.org/10.1093/eurheartj/ehab111
    Microbiota regulate innate immune signaling and protective immunity against cancer
    Xing, C., Wang, M., Ajibade, A. A., Tan, P., Fu, C., Chen, L., Zhu, M., Hao, Z. Z., Chu, J., Yu, X., Yin, B., Zhu, J., Shen, W. J., Duan, T., Wang, H. Y., & Wang, R. F. (2021). Microbiota regulate innate immune signaling and protective immunity against cancer. Cell Host and Microbe, 29(6), 959-974.e7. https://doi.org/10.1016/j.chom.2021.03.016
    Valve Academic Research Consortium 3
    VARC-3 WRITING COMMITTEE: (2021). Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. Journal of the American College of Cardiology, 77(21), 2717-2746. https://doi.org/10.1016/j.jacc.2021.02.038
    If you have a featured publication, for example on a journal cover, please let us know so we can include it in our next issue.
    Funding Opportunities
    Cures Within Reach
    Key Dates Proposals due August 6 This funding opportunity is part of CWR's new Diversity, Equity & Inclusion (DEI) community. More info about open DEI RFPs is available at https://bit.ly/cwrrfps. Grants will be awarded for clinical repurposing trials:
    • In any disease led by underserved PIs based in low and lower-middle income countries (as defined by the World Bank); budgets of up to $50,000 accepted; proposals due August 6
    NINDS Diversity Supplement program
    Key Date
    Application Due Date Funding Decision November 16 to February 15 March February 16 to May 15 June August 1 to November 15 December
    The National Institute of Neurological Disorders and Stroke (NINDS) has an opportunity to apply for additional funding to support a diverse trainee in your laboratory. NINDS uses the Diversity Supplement program to provide “bridge funds” while the supplementee gains the research experience, preliminary data, and other requirements to develop an application for more traditional NIH funding such as a National Research Service Award (NRSA) or Career Development Award. Specific NINDS procedures and supplementary information can be found at https://www.ninds.nih.gov/Funding/Training-Career-Development/Award/SUP-Research-Supplements-Promote-Diversity-Health-Related#DiversitySupplements . Funding decisions for NINDS supplement applications will only be made three times a year, namely by the end of March, June, and December. If you have any questions about our diversity programs, please feel free to contact NINDSDiversityTraining@mail.nih.gov.
    Cures Within Reach
    Key Date Proposals due July 30 and August 6 The deadline for the Cures Within Reach Request for Proposals (RFP) for US-based underrepresented racial / ethnic minority PIs is July 30, 2021. This funding opportunity is part of CWR's new Diversity, Equity & Inclusion (DEI) community. More info about our open DEI RFPs is available at https://bit.ly/cwrrfps. At least three grants will be awarded for clinical repurposing trials:
    • In any disease led by US-based racial / ethnic minority PIs underrepresented in biomedical research (as defined by the NIH); budgets of up to $70,000 accepted; proposals due July 30
    • Led by Chicagoland-based PIs addressing racial / ethnic health disparities (as defined by the NIH); budgets of up to $80,000 accepted; must include community-based collaborators; proposals due July 30
    • In any disease led by underserved PIs based in low and lower-middle income countries (as defined by the World Bank); budgets of up to $50,000 accepted; proposals due August 6
    NINDS Diversity Supplement program
    Key Dates November 16 to February 15 (Application Due Date); March (Funding Decision) February 16 to May 15 (Application Due Date); June (Funding Decision) August 1 to November 15 (Application Due Date); December (Funding Decision) The National Institute of Neurological Disorders and Stroke (NINDS) has an opportunity to apply for additional funding to support a diverse trainee in your laboratory. NINDS uses the Diversity Supplement program to provide “bridge funds” while the supplementee gains the research experience, preliminary data, and other requirements to develop an application for more traditional NIH funding such as a National Research Service Award (NRSA) or Career Development Award. Specific NINDS procedures and supplementary information can be found at https://www.ninds.nih.gov/Funding/Training-Career-Development/Award/SUP-Research-Supplements-Promote-Diversity-Health-Related#DiversitySupplements. Funding decisions for NINDS supplement applications will only be made three times a year, namely by the end of March, June, and December. If you have any questions about our diversity programs, please feel free to contact NINDSDiversityTraining@mail.nih.gov.
    Houston Methodist Academic Institute Orthopedics Pilot Project Initiative Request for Applications
    Key Dates Applications Due: Noon on Aug. 11, 2021 Applications Reviewed: August-September 2021 Awards Announced: September-October 2021 Estimated Funding Start Date: January 1, 2022
    Houston Methodist Academic Institute is pleased to reissue the Orthopedics Pilot Project Initiative Request for Applications (RFA) in the field of Orthopedics, Musculoskeletal Regeneration, and Orthopedic Surgery. The Houston Methodist Orthopedics & Sports Medicine Center of Excellence (COE) offers the latest cutting-edge technologies and rehabilitation strategies to restore mobility and quality of life. Applications may address any challenge to advance the field of Orthopedics, such as personalized therapeutic strategies, personalized metal implants, effective restorative cell therapy, and implant coatings and alternatives. Any Houston Methodist-employed faculty with a primary HMAI academic appointment is eligible to apply as a Principal Investigator (PI). Houston Methodist-employed, non-independent researchers with a primary HMAI faculty appointment (e.g., research scientists, research associates and instructors) are eligible to apply as a co-Principal Investigator (Co-PI). Non-independent investigators must have the full and written support of his/her department chair, direct scientific or clinical supervisor; and have an eligible Co-PI to support the application. Applications may include a Co-PI from a collaborating institution; however, the contact PI must meet all Houston Methodist eligibility requirements. Competitive applications should propose an interdisciplinary, multi-faceted, and collaborative strategy that promotes creativity and innovation. Each proposal must include at least one basic/translational scientist and one practicing clinician. In addition, at least one PI must be affiliated with the Houston Methodist Orthopedics & Sports Medicine COE. Investigators can serve on multiple applications; however, each application must have a distinct project focus and investigative team. An investigator should pair with a different clinical or scientific partner on additional applications. Successful applications will receive up to $50,000 in direct costs only, for up to 1 year. Full details regarding this funding opportunity can be found in the attached RFA. Applications must be received by noon (CST), Aug. 11, 2021, via electronic submission to: academicaffairs@houstonmethodist.org.
    Dyer Fellowship at Houston Methodist
    Houston Methodist is pleased to announce the availability of the Dyer Fellowship through the philanthropy of Connie and Byron Dyer. Key Dates
    Proposals due Oct. 1
    Purpose of Fellowship The support provided by the Dyer Fellowship must be used for a program or activity that will benefit and improve patient care at Houston Methodist. The benefit can be provided in one of three ways. Support for a Houston Methodist trainee or medical staff member to travel to another medical center to learn a clinical technique not available at Houston Methodist, or alternatively to bring a recognized expert to Houston Methodist to teach new methods to our staff. Support for a Houston Methodist trainee or medical staff member to conduct a focused research project in the areas of quality and patient safety. Support for a Houston Methodist trainee or medical staff member to develop a focused educational program that will improve an aspect of patient care at Houston Methodist. Nomination Process Nominations will be open once a year. Applications must be received by Oct. 1. The application must include
    • nomination letter
    • candidate’s proposal and
    • candidate’s curriculum vitae.
    The nomination letter should include, in less than three pages:
    • funding requested (not to exceed $10,000);
    • proposed use of funding;
    • proposed start date and term of award;
    • candidate’s pertinent training and accomplishments;
    • other support and resources that will be made available to the candidate;
    • envisioned impact of award on the candidate and on Houston Methodist;
    • specific commitment of release time from other duties for the candidate. If the nominator is not in a position to commit resources or release time for the candidate, an additional letter must be provided from the unit director who can make such commitments on the candidate’s behalf.
    The candidate’s proposal should describe, in less than three pages, the proposed program of academic work that the candidate will undertake. Selection Process
    • Continuing Medical Education (CME) Committee will review proposals by Nov. 10.
    • Award decision will be approved by the IAM Council of Chairs.
    • Review criteria
    • Quality of applicant based on CV, nomination letter; references and / or personal interview may be required at committee’s discretion.
    • Appropriateness of use of funds (i.e. travel costs, salaries, research projects, education, etc.), budget and cost sharing.
    • Importance and impact of proposal to patient care.
    Appointment Process The CME Committee will notify the recipient, the nominator and the Houston Methodist Hospital Foundation of the decision on all applications. The Foundation will work with awardees to arrange the details of providing funding. The Foundation will also notify the donors of the individuals and projects that are being funded. Awards will be funded after Jan. 1. Post-Appointment Process
    • Foundation may host a lunch or dinner event for fellows and donors.
    • Each Fellow will prepare a brief final report on the activity and outcomes of the Fellowship.
    • Each Fellow will be required to present the outcomes of the Fellowship at a designated Houston Methodist Grand Rounds.
    Submit your proposal here.
    Bridge to Translational Research Initiative (B2TRI)
    The Houston Methodist Academic Institute (HMAI) is pleased to reissue the Bridge to Translational Research Initiative (B2TRI) Request for Applications, which provides funding for promising and clinically relevant research (molecular, cellular or early pre-clinical research) to advance for TRI funding consideration. Typically, B2TRI eligible projects are not yet positioned for development under Good Laboratory Practices (GLP) conditions or Good Manufacturing Practices (GMP), or for clinical trials. Key Dates Applications Due: Oct. 8, 2021, at Noon CST Applications Reviewed: October - November 2021 Awards Announced: December 2021 Estimated Funding Start Date: Jan. 1, 2022 Academic Affairs is pleased to introduce the Houston Methodist Intramural Awards portal. Applications for the Bridge to Translational Research Initiative must be submitted through this portal. More details are provided in the Submission Guidelines section of the attached RFA. Webinar and Q&A dates are listed below. All sessions will be held via Microsoft Teams. Please reach out to Academic Affairs for meeting details. Submission Portal Webinar: Sept. 16, 2021, Noon – 1 pm CST Submission Portal Q&A Sessions: Oct. 4-7, 2021, 11 am – Noon CST Eligibility Any Houston Methodist-employed faculty with a primary HMAI academic appointment is eligible to apply as a Principal Investigator (PI). Proposed projects must be based on Houston Methodist Inventions. Before applying to the B2TRI program, applicants must consult with the Houston Methodist Office of Technology Transfer (OTT), for further details regarding eligibility. Sign off from an OTT representative is a required application component. To help inform the study design as a strategic approach to translation, interested applicants are required to meet with the Office of Regulatory Affairs and Translational Management (Christina Talley - ctalley@houstonmethodist.org). Sign off from an ORATM representative is a required application component. Funding Information Applicants may propose a project funding period of up to six months and a budget of up to $50,000 in total costs, direct costs only. Salary support is not permitted. Subcontracts are not eligible for B2TRI funds. No cost sharing or matching is available or required. The number of awards given under this funding opportunity is subject to the quality of applications, the availability of funds, and program funding priorities. For selected applications, receipt of these funds is contingent upon the acknowledgement and acceptance of the Terms of Award Agreement, which is described in the Terms of Agreement with Inventors section of the RFA. Summary of Submission Requirements Please review the attached RFA for full details. Project Summary/ Abstract
    • Application Questions
    • List of References Cited
    • Budget (budget template provided)
    • Budget Justification
    • Biosketch
    • B2TRI Collaborating Offices Sign-off Form
    • Supervisor Support Letter (if applicable)
    Applications must be submitted via the Houston Methodist Intramural Awards portal (https://intramural-awards.houstonmethodist.org/) by October 8, 2021, at noon (CST). Email submission will not be accepted. Please see the provided Applicant Guide document for additional details. A webinar and Q&A sessions will be held to help familiarize applicants and administrators with the submission portal. Dates are provided in the Key Dates section of the attached RFA. Link to B2TRI opportunity details page: https://intramural-awards.houstonmethodist.org/#competitionDetail/1845950.